Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.
Clinical trial NCT01788007 · COMPLETED
Trial details
- NCT number
- NCT01788007
- Sponsor
- Sun Pharmaceutical Industries, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-10-01
- Enrollment
- 443
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.